GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Parnell Pharmaceuticals Holdings Ltd (OTCPK:PARNF) » Definitions » Total Assets

Parnell Pharmaceuticals Holdings (Parnell Pharmaceuticals Holdings) Total Assets : $24.00 Mil (As of Dec. 2018)


View and export this data going back to 2014. Start your Free Trial

What is Parnell Pharmaceuticals Holdings Total Assets?

Parnell Pharmaceuticals Holdings's Total Assets for the quarter that ended in Dec. 2018 was $24.00 Mil.

Total Assets is connected with ROA %. Parnell Pharmaceuticals Holdings's annualized ROA % for the quarter that ended in Dec. 2018 was 0.39%. Total Assets is also linked to Revenue through Asset Turnover. Parnell Pharmaceuticals Holdings's Asset Turnover for the quarter that ended in Dec. 2018 was 0.81.

Parnell Pharmaceuticals Holdings Total Assets Historical Data

The historical data trend for Parnell Pharmaceuticals Holdings's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Parnell Pharmaceuticals Holdings Total Assets Chart

Parnell Pharmaceuticals Holdings Annual Data
Trend Jun12 Jun13 Jun14 Dec15 Dec16 Dec17 Dec18
Total Assets
Get a 7-Day Free Trial 44.70 33.49 34.96 23.09 24.00

Parnell Pharmaceuticals Holdings Semi-Annual Data
Jun12 Jun13 Jun14 Dec15 Dec16 Dec17 Dec18
Total Assets Get a 7-Day Free Trial 44.70 33.49 34.96 23.09 24.00

Parnell Pharmaceuticals Holdings Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Parnell Pharmaceuticals Holdings's Total Assets for the fiscal year that ended in Dec. 2018 is calculated as

Total Assets=Total Equity (A: Dec. 2018 )+Total Liabilities (A: Dec. 2018 )
=-13.282+37.285
=24.00

Parnell Pharmaceuticals Holdings's Total Assets for the quarter that ended in Dec. 2018 is calculated as

Total Assets=Total Equity (Q: Dec. 2018 )+Total Liabilities (Q: Dec. 2018 )
=-13.282+37.285
=24.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Parnell Pharmaceuticals Holdings  (OTCPK:PARNF) Total Assets Explanation

Total Assets is connected with ROA %.

Parnell Pharmaceuticals Holdings's annualized ROA % for the quarter that ended in Dec. 2018 is

ROA %=Net Income (Q: Dec. 2018 )/( (Total Assets (Q: Dec. 2017 )+Total Assets (Q: Dec. 2018 ))/ count )
=0.093/( (23.092+24.003)/ 2 )
=0.093/23.5475
=0.39 %

Note: The Net Income data used here is one times the annual (Dec. 2018) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Parnell Pharmaceuticals Holdings's Asset Turnover for the quarter that ended in Dec. 2018 is

Asset Turnover
=Revenue (Q: Dec. 2018 )/( (Total Assets (Q: Dec. 2017 )+Total Assets (Q: Dec. 2018 ))/ count )
=19.031/( (23.092+24.003)/ 2 )
=19.031/23.5475
=0.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Parnell Pharmaceuticals Holdings Total Assets Related Terms

Thank you for viewing the detailed overview of Parnell Pharmaceuticals Holdings's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Parnell Pharmaceuticals Holdings (Parnell Pharmaceuticals Holdings) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Parnell Pharmaceuticals Holdings Ltd (OTCPK:PARNF) » Definitions » Total Assets
Comparable Companies
OWCP CXUS CANB CNABQ LITH APPB GSRX PCYN EVIO GENH ZTS TSE:4502 XTER:MRK HKSE:03692 TSE:4523 SZSE:000661 TSE:4507 SZSE:000538 NSE:SUNPHARMA SZSE:300601
Traded in Other Exchanges
N/A
Address
476 Gardeners Road, Unit 4, Century Estate, Alexandria, Sydney, NSW, AUS, 2015
Website
https://www.parnell.com
Parnell Pharmaceuticals Holdings Ltd is an Australia based veterinary pharmaceutical company. It is focused on developing, manufacturing and commercializing animal health solutions. The group manufactures and market products for companion animals and production animals. The firm also has a pipeline of drug products like Zydax, PAR121 and PAR122 and Luminous which covers therapeutic areas in orthopedics, dermatology, and nutraceuticals. The operating segments of the company are Companion animal, Production animal - U.S., Production animal - rest of world and Contract Manufacturing. It operates internationally and generates the majority of the revenue from the Production animal - U.S. segment which covers the group's reproductive hormone portfolio across production animal in the USA.